Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RAS-mutant Colorectal Cancer”

Showing 6 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07213570
What this trial is testing

STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
National Cancer Institute, Naples 60
Testing effectiveness (Phase 2)UnknownNCT01802645
What this trial is testing

Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer
Technische Universität Dresden 91
Testing effectiveness (Phase 2)Ended earlyNCT04853043
What this trial is testing

Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Utah 7
Testing effectiveness (Phase 2)UnknownNCT01110785
What this trial is testing

Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Leiden University Medical Center 46
Large-scale testing (Phase 3)Study completedNCT04737187
What this trial is testing

Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients

Who this might be right for
Refractory Metastatic Colorectal Cancer
Taiho Oncology, Inc. 492
Large-scale testing (Phase 3)Not Yet RecruitingNCT07362836
What this trial is testing

Fruquintinib Versus Bevacizumab Plus Chemotherapy in Second-Line RAS-Mutant Metastatic Colorectal Cancer (FRU-RAS)

Who this might be right for
Colorectal Cancer
Fudan University 224

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation